» Articles » PMID: 22492217

Suppression of Dendritic Cell Maturation and T Cell Proliferation by Synovial Fluid Myeloid Cells from Mice with Autoimmune Arthritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2012 Apr 12
PMID 22492217
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine whether myeloid cells (such as granulocytes) present in the synovial fluid (SF) of arthritic joints have an impact on adaptive immunity. Specifically, we investigated the effects of SF cells harvested from the joints of mice with proteoglycan-induced arthritis (PGIA), on dendritic cell (DC) maturation and antigen-specific T cell proliferation.

Methods: We monitored DC maturation (MHCII and CD86 expression) by flow cytometry upon coculture of DCs with SF cells or spleen myeloid cells from mice with PGIA. The effects of these myeloid cells on T cell proliferation were studied using T cells purified from PG-specific T cell receptor (TCR)-transgenic (Tg) mice. Phenotype analysis of myeloid cells was performed by immunostaining, reverse transcription-polymerase chain reaction, Western blotting, and biochemical assays.

Results: Inflammatory SF cells significantly suppressed the maturation of DCs upon coculture. PG-TCR-Tg mouse T cells cultured with antigen-loaded DCs showed dramatic decreases in proliferation in the presence of SF cells. Spleen myeloid cells from arthritic mice did not have suppressive effects. SF cells were unable to suppress CD3/CD28-stimulated proliferation of the same T cells, suggesting a DC-dependent mechanism. SF cells exhibited all of the characteristics of myeloid-derived suppressor cells (MDSCs) and exerted suppression primarily through the production of nitric oxide and reactive oxygen species by granulocyte-like cells.

Conclusion: SF in the joints of mice with PGIA contains a population of granulocytic MDSCs that potently suppress DC maturation and T cell proliferation. These MDSCs have the potential to limit the expansion of autoreactive T cells, thus breaking the vicious cycle of autoimmunity and inflammation.

Citing Articles

Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.

Fujikawa Y, Sendo S, Del Peral Fanjul A, Yamada H, Uto K, Yamamoto Y Front Immunol. 2024; 15:1168323.

PMID: 38566990 PMC: 10985135. DOI: 10.3389/fimmu.2024.1168323.


Myeloid-derived suppressor cells promote allograft survival by suppressing regulatory T cell dysfunction in high-risk corneal transplantation.

Lee S, Blanco T, Musayeva A, Dehghani S, Narimatsu A, Forouzanfar K Am J Transplant. 2024; 24(9):1597-1609.

PMID: 38514014 PMC: 11390336. DOI: 10.1016/j.ajt.2024.03.022.


Diverse functions of myeloid-derived suppressor cells in autoimmune diseases.

Xiong X, Zhang Y, Wen Y Immunol Res. 2023; 72(1):34-49.

PMID: 37733169 PMC: 10811123. DOI: 10.1007/s12026-023-09421-0.


JAK1/2 inhibitor ruxolitinib promotes the expansion and suppressive action of polymorphonuclear myeloid-derived suppressor cells via the JAK/STAT and ROS-MAPK/NF-κB signalling pathways in acute graft-versus-host disease.

Cao Y, Wang J, Jiang S, Lyu M, Zhao F, Liu J Clin Transl Immunology. 2023; 12(2):e1441.

PMID: 36855558 PMC: 9968240. DOI: 10.1002/cti2.1441.


Myeloid-derived suppressor cell: A crucial player in autoimmune diseases.

Xu D, Li C, Xu Y, Huang M, Cui D, Xie J Front Immunol. 2022; 13:1021612.

PMID: 36569895 PMC: 9780445. DOI: 10.3389/fimmu.2022.1021612.


References
1.
Yamamoto T, Nishiura H, Nishida H . Molecular mechanisms to form leukocyte infiltration patterns distinct between synovial tissue and fluid of rheumatoid arthritis. Semin Thromb Hemost. 1996; 22(6):507-11. DOI: 10.1055/s-2007-999052. View

2.
Banchereau J, Steinman R . Dendritic cells and the control of immunity. Nature. 1998; 392(6673):245-52. DOI: 10.1038/32588. View

3.
Xu W, Firestein G, Taetle R, Kaushansky K, Zvaifler N . Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest. 1989; 83(3):876-82. PMC: 303761. DOI: 10.1172/JCI113971. View

4.
Glant T, Finnegan A, Mikecz K . Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol. 2003; 23(3):199-250. DOI: 10.1615/critrevimmunol.v23.i3.20. View

5.
Berlo S, Guichelaar T, Ten Brink C, van Kooten P, Hauet-Broeren F, Ludanyi K . Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice. Arthritis Rheum. 2006; 54(8):2423-33. DOI: 10.1002/art.22013. View